Moirai Biodesign

Moirai Biodesign is a private, pre-revenue biotechnology platform company founded in 2016 (contradicting initial data) and based in Barcelona, Spain. Its core offering is the 'MoiRNAiFold' platform, a state-of-the-art computational RNA design engine powered by AI algorithms, which it applies to create novel diagnostics and therapeutic RNA molecules. The company has secured non-dilutive funding from the Spanish CDTI and is advancing both a diagnostics technology and a therapeutic design software, positioning itself at the intersection of AI-driven biodesign and RNA medicine.

MoiRNAiFold: An AI-based computational platform for the design of a wide array of RNA molecules, from small RNAs and ribozymes to long mRNAs, for therapeutic and diagnostic applications.

Moirai competes in the crowded AI-for-drug-discovery sector against companies like Absci, Recursion, and Exscientia, and more specifically in RNA design against firms such as Atomic AI and Deep Genomics. Its diagnostic sensor technology also faces competition from established molecular diagnostic players and new entrants in point-of-care testing.